Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.37 - $7.24 $212,402 - $1.12 Million
155,038 Added 30.64%
661,038 $4.71 Million
Q2 2022

Aug 15, 2022

BUY
$2.7 - $4.59 $1.37 Million - $2.32 Million
506,000 New
506,000 $2.05 Million
Q2 2021

Aug 13, 2021

SELL
$24.14 - $37.68 $482,800 - $753,600
-20,000 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$19.0 - $57.61 $380,000 - $1.15 Million
20,000 New
20,000 $1.05 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $55.1M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.